Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer

Clinical trial NCT03128619 · TERMINATED

Trial details

NCT number: NCT03128619
Sponsor: Jonsson Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Estrogen Receptor Positive HER2/Neu Negative Invasive Breast Carcinoma Multifocal Breast Carcinoma Postmenopausal Progesterone Receptor Positive Stage I Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer

Start date: 2017-08-02
Primary completion: 2022-03-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.